Professor David Haslam
Professor David Haslam is past-President and past Chairman of Council of the Royal College of General Practitioners, past-President of the British Medical Association, a former vice-chairman of the Academy of Medical Royal Colleges, visiting Professor in Primary Health Care at de Montfort University, Leicester, and Professor of General Practice at the University of Nicosia, Cyprus.
He was a GP in Ramsey, Cambridgeshire, for many years and has been an expert member of the NHS National Quality Board, chair of the NQB Quality Information Committee, and National Clinical Adviser to both the Care Quality Commission and the Healthcare Commission.
David is a Fellow of the:
- Royal College of GPs
- Faculty of Public Health
- Academy of Medical Educators
- Royal Society of Medicine
- Royal College of Physicians.
He’s written 13 books, mainly on health topics for the lay public and translated into 13 languages, and well over a thousand articles for the medical and lay press.
In 2014 he was named by Debretts and the Sunday Times as one of the 500 most influential and inspirational people in the United Kingdom. He was awarded a CBE in 2004 for services to medicine and health care, and has been awarded honorary doctorates by the University of Birmingham and the University of East Anglia.
Dr Rosie Benneyworth
Rosie has been a Non-Executive Director with NICE since January 2016 and Vice Chair since May 2017 where she oversees the technology appraisals and highly specialised technologies appeals process. She has been involved with NICE for several years, having previously been a member of a guideline development group and a NICE Fellow.
Rosie currently works as the Director of Strategic Clinical Services Transformation for Somerset Clinical Commissioning Group, where she is responsible for developing and implementing a joint commissioning strategy with the local authority for the Somerset population.
She has been a GP for 15 years and worked as a principal, salaried and sessional GP during this time. Prior to her current role, Rosie was Managing Director of the South West Academic Health Science Network (AHSN), where she was Vice Chair of the AHSN network and led the Patient Safety Collaboratives. Rosie has also held many clinical leadership roles mainly around service redesign and improvement programmes.
Professor Sheena Asthana
Professor Sheena Asthana is Professor of Health Policy at the University of Plymouth. Her research and teaching focus is on inequalities in health and health care, international public health and evidence-based public health.
She has worked with NICE to produce systematic reviews, evidence synthesis and economic analyses to inform our public health programme. Sheena brings
Professor Angela Coulter
Professor Angela Coulter is a health policy analyst and researcher, with special interests in patient and public involvement. Her previous roles include Chief Executive of Picker Institute Europe, Director of Policy and Development at the King’s Fund, Director of the Health Services Research Unit at the University of Oxford and Director of Global Initiatives at the Informed Medical Decisions Foundation.
Angela has published more than 300 research papers and reports. She is the author of several books including The European Patient of the Future, winner of the 2004 Baxter Award. Her work has received awards from the Donabedian Foundation of Barcelona in 2012 and the International Shared Decision Making Conference in 2013.
Professor Martin R Cowie
Professor Martin Cowie is Professor of Cardiology at Imperial College and an Honorary Consultant Cardiologist at the Royal Brompton and Harefield NHS Foundation Trust. Since 2003 he has been a clinical advisor for NICE on our acute and chronic heart failure guidelines, quality standards, commissioning guides, patient decision aids, and technology appraisals. In 2012 he became a NICE
His major clinical and research interests are in health technology assessment and the delivery of efficient and effective care for patients with heart failure, focusing on new technologies: diagnostics, drugs or devices.
Elaine Inglesby-Burke has been a registered nurse since 1980. Her previous roles include being a nurse specialist manager at St Helens and Knowsley Hospital Trust and Director of Nursing at The Walton Centre in Liverpool. Most recently, Elaine was appointed Deputy Chief Executive at Salford Royal NHS Foundation Trust. She is also on the governing body at St Helens Clinical Commissioning Group and Willowbrook Hospice in St Helens.
Elaine has also played a significant role in national health campaigns,
Last year, Elaine was awarded a CBE
Tim has worked in the life sciences industry for thirty years. His career has spanned global health technology companies across Europe and North America, including GSK, GE and Philips.
Between 2007 and 2015 he served on ten Boards, five as Chair, where he successfully executed two trade sales and raised significant equity financing, including an IPO. Tim’s current governance portfolio covers Life Sciences, Healthcare and Education, both public and private, including board roles as Non-Executive Director at NICE, various European MedTech Supervisory Board roles, and Professor of Practice at King’s College London’s School of Management and Business.
Tim is currently NICE's Senior Independent Director.
Dr Rima Makarem
Dr Rima Makarem has been Audit Chair in several NHS organisations, recently at NHS London and now at University College London Hospital. She is also the Chair
Rima has previously worked in the pharmaceutical industry in a number of roles including Director of Competitive Excellence at GlaxoSmithKline.
Tom Wright CBE
Tom Wright CBE is Chief Executive of Guide Dogs. He was previously CEO of Age UK and chair of the Richmond Group of 14 leading health charities. Tom has extensive experience in the health and social care sector.
Sir Andrew Dillon
Sir Andrew Dillon joined the NHS in 1975 and has held a number of senior management positions, including General Manager of the Royal Free Hospital and Chief Executive of St George's Healthcare NHS Trust. He joined the National Institute for Health and Care Excellence as its founding Chief Executive in 1999.
Professor Gillian Leng CBE
Deputy Chief Executive and Director of Health and Social Care
Professor Gillian Leng is the Deputy Chief Executive at NICE, the Director of Health and Social Care, and a visiting professor at King's College London.
Gillian trained in medicine at
At NICE, Gillian has been responsible for the initial set up and running of the clinical guidelines programme, for establishing the NICE implementation function, and for setting up NHS Evidence. More recently she has been responsible for the transfer of the National Prescribing Centre into NICE, for establishing the NICE accreditation programme, and for new work on Quality Standards across health and social care.
Gillian is also Director of the Health and Social Care Programme and since January 2015 is leading the public health team at NICE.
Director of Business Planning and Resources
Ben Bennett joined NICE in 2003. As director of business planning and resources, Ben is responsible for the Institute's business planning process and corporate services including finance, human resources, information technology, estates and facilities.
Ben graduated from the University of Keele with a degree in economics and computer science. He trained as an accountant on the NHS graduate financial management scheme and is a member of the Chartered Institute of Public Finance and Accountancy (CIPFA).
Before joining NICE Ben worked for the Audit Commission, where he was involved in a range of work including value for money reviews and financial audit for both health and local government clients. Before
Centre for Guidelines Director
Mark Baker is the Director of the Centre for Guidelines (CfG) and is responsible for designing and operating methods and systems to produce clinical guidelines for the NHS. CfG is also responsible for the work of the Medicines and Prescribing Centre including summaries of evidence on new medicines and unlicensed and off-label medicines and the management of the contract for the British National Formulary.
Before joining NICE, Mark was Lead Cancer Clinician at the Leeds Teaching Hospitals and National Clinical Lead for Cancer Peer Review. He has previously worked in transplantation, academic medicine and public health medicine and was Chief Executive of Bradford Teaching Hospitals for six years and a Director of Research and Development.
Immediately before joining NICE, Jane was head of corporate communications at the Medical Research Council, the UK's largest publicly funded medical research organisation. Her remit covered the full spectrum of corporate communications, from strategic development, public involvement and consultation, to media relations and brand management. Jane has worked extensively in the political field in Canada, including as Press secretary for the official opposition and former prime minister of Canada, and as Director of communications, Canadian Federation of Labour.
Jane has also held senior positions in charitable organisations including the Scout Association and the International Planned Parenthood Federation.
Director of Evidence Resources
Alexia Tonnel is director of Evidence Resources. She is responsible for the delivery of the NHS Evidence and UK PharmaScan services and leads the information management and technology, user research and information services resources of NICE.
Alexia studied business and management in France after which she completed a Master of Science in International Accounting and Finance at the London School of Economics and Political Science.
Before joining NICE, Alexia was a Director with Deloitte where she advised a range of clients in the healthcare and life science industries on policy and strategy development as well as programme implementation.
Acting Director – Centre for Health Technology Evaluation
Mirella is responsible for the Centre for Health Technology Evaluation, a part of NICE that develops guidance and advice for the NHS on a wide range of technologies, including pharmaceutical products, medical devices, diagnostics and digital products as well as interventional procedures. The centre also leads for NICE on science policy and research, and provides services for the life sciences industry through the Office for Market Access and Scientific Advice.
Mirella works with health services, government policymakers, the life sciences industry, patient groups, and researchers to maximise the effectiveness of our work in these areas.
Mirella joined us in 2004, having previously worked for 15 years as a commissioner in the NHS. She has an MBA and a Masters in Medical Ethics and Law from Keele University. Her interests in medical ethics include measuring cost-effectiveness of interventions to improve safety in healthcare, and incorporating ethical considerations into health technology assessments.
The NICE Board has the following
- Audit and Risk Committee
- Remuneration Committee